Cells lacking MHC class I

This entry describes a cellular phenotype or state, specifically cells that do not express MHC class I molecules on their surface. It is not a molecular therapeutic target in the conventional sense (e.g., a receptor, enzyme, or transporter). In the context of disease, particularly cancer, cells lacking MHC class I are a pathological phenomenon. This absence allows cancer cells to evade detection and destruction by cytotoxic T lymphocytes (CTLs), which rely on MHC class I for antigen presentation. Therefore, 'cells lacking MHC class I' represents a mechanism of immune evasion rather than a discrete, druggable molecular entity. While this characteristic is not a target itself, understanding the mechanisms leading to MHC class I loss, or developing therapies that target these MHC-deficient cells (e.g., NK cell-based therapies), are areas of therapeutic interest.